What’s Next in Healthcare Innovation?
Thursday, February 4, 2021 | 1 – 2 p.m. ET
Digital health expanded exponentially in 2020 during the global pandemic. As new vaccines and treatments provide hope that normality of some sort may resume in 2021, breakthroughs enabled by the accelerated pace of innovation will better equip us to face new challenges. With telemedicine now adopted widely, what other types of health technologies are emerging faster than we may have thought possible just a year ago? And how will they change the patient experience?
In this program we’ll hear from digital health and technology leaders and learn more about how technology can inform care and promote health. We’ll also hear about emerging digital infrastructures being created to better serve patients and keep up with the pace of technology. What types of home technologies and wearables are gaining traction? How are hospitals using AI applications? And what will healthcare look like in the next few years?
Join us for this exciting panel discussion led by Kathy Sucich, VP at Dimensional Insight, and learn about the next innovations powering healthcare.
John Brownstein, PhD
Chief Innovation Officer,
Boston Children’s Hospital
John Brownstein, PhD, is the chief innovation officer at Boston Children’s Hospital.
Dr. Brownstein was trained as an epidemiologist at Yale University, where he received his PhD. His research interests are in the development of methods and data sources in public health informatics that focus on two major areas: (1) the design, evaluation, and implementation of public health surveillance systems, and (2) statistical modeling of public health surveillance data to improve prevention and control activities. This research has focused on a variety of infectious disease systems, including malaria, HIV, dengue, West Nile virus, Lyme disease, RSV, salmonella, listeria, and influenza.
Dr. Brownstein has advised the World Health Organization, Institute of Medicine, the U.S. Departments of Health and Human Services and Homeland Security, and the White House on real-time public health surveillance data. He has used this experience in his role as vice president of the International Society for Disease Surveillance. He has authored more than one hundred articles in the area of disease surveillance. This work has been reported on widely, including pieces in the New England Journal of Medicine, Science, Nature, New York Times, The Wall Street Journal, CNN, National Public Radio, and the BBC.
Alistair Erskine, M.D.
Chief Digital Health Officer, Massachusetts General Brigham
Alistair Erskine, M.D., is the Chief Digital Health Officer at Massachusetts General Brigham, teaching hospitals for Harvard Medical School. He is responsible for sequencing innovative technologies, harmonizing data across the clinical care, research, and health plan enterprise, and aligning digital patient experience with emerging patient consumerism trends. Dr. Erskine leads the Digital Health department responsible for the design and configuration of Mass General Brigham’s clinical information systems and virtual care services. He also leads the Enterprise Data & Digital Health program, a targeted five-year initiative to advance foundational investments in digital patient experience, system operations, and clinical care to enable Mass General Brigham to engage across local, national, and global markets.
Prior to Mass General Brigham, Dr. Erskine was Geisinger Health’s Chief Informatics Officer and oversaw Geisinger’s Unified Data Architecture, a hedged data management environment powered by Hadoop/Big Data and traditional relational database systems. In previous roles, he was appointed to the Virginia Governor’s Health Information Technology Commission by Executive Order and was a voting member of the Health Information Technology Standards Committee. He presents and publishes on the topic of digital health, clinical transformation, and virtual care in peer-reviewed literature and serves on the Boards of several companies.
Dr. Erskine trained at Brown University and Virginia Commonwealth University Health System and is triple Board-Certified in Internal Medicine, Clinical Informatics, and Pediatrics. He completed a two-year degree program at MIT Sloan School of Management, with a specialization in Business Analytics and Artificial Intelligence. He has been practicing hospital medicine for 15 years and teaches at Harvard Medical School.
YiDing Yu, MD
Chief Medical Officer, Olive
YiDing Yu, MD, is Chief Medical Officer at Olive. She is a practicing physician and serial entrepreneur, passionate about transforming the way we imagine and deliver healthcare. Named woman entrepreneur of the year in 2018 by the Cartier Women’s Initiative Awards, Dr. Yu is a skilled business operator and passionate public speaker who has launched and scaled innovations across the healthcare ecosystem.
Prior to Olive, Dr. Yu was Chief Medical Officer at Verata Health, a top venture-backed AI company, where she led marketing, customer success, and payer partnerships, and pioneered Frictionless Prior Authorization® for payers and providers. She also founded and served as CEO of Twiage, an award-winning healthcare tech platform for emergency responders. Dr. Yu began her career at Mass General Brigham, where she received the President’s Prize of Value-Based Healthcare Delivery. She’s also served as Chief Innovation Engineer of Atrius Health in Boston. Recognized throughout her career for her groundbreaking work, Dr. Yu has won top innovation prizes from the American Heart Association, the American Medical Association, and the Cleveland Clinic.